Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Obstetrics and Gynecology|September 1, 1995
Transplacental needle passage in early amniocentesis and pregnancy lossR R Bravo, L P Shulman, O P Phillips, et al.Fertility and Sterility|October 1, 1991
Segregation analysis and genetic counseling when both parents carry balanced chromosomal translocationsO P Phillips, A T Tharapel, L P Shulman, et al.Prenatal Diagnosis|March 4, 2000
Fetal 'space-suit' hydrops in the first trimester: differentiating risk for chromosome abnormalities by delineating characteristics of nuchal translucencyL P Shulman, O P Phillips, D S Emerson, et al.American Journal of Obstetrics and Gynecology|July 14, 1998
Primed in situ labeling for rapid prenatal diagnosisG V Velagelati, L P Shulman, O P Phillips, et al.American Journal of Obstetrics and Gynecology|April 1, 1993
Cystic fibrosis mutations in white and black Americans: an approach to identification of unknown mutations with implications for cystic fibrosis screeningO P Phillips, S Elias, D Woods, et al.Obstetrics and Gynecology|April 1, 1994
Amniocentesis performed at 14 weeks' gestation or earlier: comparison with first-trimester transabdominal chorionic villus samplingL P Shulman, S Elias, O P Phillips, et al.American Journal of Obstetrics and Gynecology|November 1, 1994
Family planning decisions after prenatal detection of fetal abnormalitiesL P Shulman, C Grevengood, O P Phillips, et al.Fetal Diagnosis and Therapy|March 1, 1993
Transvaginal chorionic villus sampling using transabdominal ultrasound guidance: a new technique for first-trimester prenatal diagnosisL P Shulman, J L Simpson, S Elias, et al.American Journal of Obstetrics and Gynecology|November 1, 1990
Direct analysis of uncultured cytotrophoblastic cells from second- and third-trimester placentas: an accurate and rapid method for detection of fetal chromosome abnormalitiesL P Shulman, A T Tharapel, C M Meyers, et al.Obstetrics and Gynecology|September 1, 1992
Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year studyO P Phillips, S Elias, L P Shulman, et al.Pageof 4